Similarly, renin inhibition with aliskiren improves insulin sensitivity, skeletal muscle glucose uptake, glucose tolerance, and insulin secretion in male rodent models of hypertension, diabetes, obesity, and metabolic syndrome [44–48]. The gene discussed is REN; the disease is obesity due to melanocortin 4 receptor deficiency.